All research papers

Imaging 131 I in mouse phantoms and living mice with the MACACO III+ Compton camera

Head-to-head comparison of 99mTc-MIP-1404 CZT SPECT/CT and ⁶⁸Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II study.

The threefold value of surgery in previously irradiated brain metastases.

Concurrent New Systemic Therapies and Radiation Therapy in Breast Cancer: Current Evidence, Future Challenges, and Expert Practice Recommendations for Low- and Middle-Income Countries.

A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.

Dosimetry and pharmacokinetics of [²²³Ra]Ra-dichloride alpha therapy in prostate cancer patients with bone metastases.

Preliminary feasibility of pre-treatment F-18-PSMA-1007 PET/CT in dose prediction for Lu-177-PSMA-I&T therapy.

Skeletal muscle radiodensity as an automated survival predictor in men with metastatic castration-resistant prostate cancer undergoing PSMA-targeted radioligand therapy.

Ultrahypofractionated linac-based radiotherapy of primary prostate cancer - early results of an Austrian nationwide registry study.

Iodine Avid Muscle Metastases Mimicking Skeletal Lesions on Whole-Body Iodine Scan in Poorly Differentiated Thyroid Carcinoma -SPECT/CT to the Rescue.

Maintenance-Induced Configuration Drift in Nuclear Medicine Quality Control: The Role of Technologists and Site Engineers.

Stereotactic radiosurgery using a self-shielded gyroscopic radiosurgery system for meningiomas: technical aspects and dosimetric results.

Inline gamma spectroscopy and liquid scintillation HPLC reveal daughters in ²²⁵Ac-radiopharmaceutical.

Renal Function During and After ¹⁷⁷Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.

Brain Surgeon Without a Scalpel: Memoir of a Stereotactic Radiosurgery Pioneer.

Frameless stereotactic radiosurgery in the management of brain metastases: long-term oncologic and toxicity outcomes.

Increasing demands on commissioning and quality assurance for cone-based multiple brain metastases robotic radiosurgery: evaluation in a custom phantom.

PSMA-avid Pleural Solitary Fibrous Tumor Incidentally Detected on [ 18 F] Piflufolastat PSMA PET/CT.

Synthesis and in vitro evaluation of pharmacokinetically optimized 99mTc-labeled cholecystokinin-2 receptor-targeted peptides for improved SPECT imaging.

Linear screening and machine learning to identify suitable candidates for active breathing control after mastectomy in left-sided breast cancer.

Rescue deep brain stimulation for recurrent essential tremor after ventral intermediate nucleus thalamotomy: illustrative cases.

Clinical and molecular features of resected breast cancer brain metastases: a single center retrospective cohort study.

Artificial intelligence (AI) uses in stereotactic radiosurgery (SRS): diagnosis with brain metastasis (BM) - A systematic review.

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.

Targeting HCC With SBRT: Practical Strategies and Immunologic Synergies.

A proof-of-concept implementation of a patient-specific Geant4 Monte Carlo dose evaluation framework for SFRT.

Tumor microenvironment-mediated hematologic toxicity of ²²⁵Ac-PSMA-617 in metastatic castration-resistant prostate cancer: mechanisms, risk stratification, and clinical management.

Dual-tracer PSMA/FDG PET/CT for lesion detection and risk stratification in biochemical recurrence with negative conventional imaging.

A Spatiotemporal Image-Guided Model of Radiopharmaceutical Transport in Heterogeneous Vasculature Prostate Tumor: A Computational Analysis of Key Parameters in Lutetium-177 PSMA Therapy.

Adding local gyro-knife radiotherapy to EGFR-TKI improves outcomes in EGFR-mutant NSCLC.

Advancing occupational radiation exposure beyond compliance.

Visual fidelity-driven quality assessment of medical image translation.

Comparison of breath hold and abdominal compression for liver SABR on C-arm Linac and MR Linac: A single institution retrospective planning study.

Lutetium-177-PSMA radioligand therapy in metastatic hormone-sensitive prostate cancer: A systematic review of efficacy, safety, and combination strategies.

From Clinical Trials to Clinical Practice-Patterns of Practice Survey on Prostate SABR in Australia and New Zealand.

Recurrent Metastatic Esthesioneuroblastoma: First-in-human α/β PRRT With Actinium-225/Lutetium-177-DOTA-LM3 SSTR Antagonist Achieving Partial Response After Failure of Lutetium-177-DOTATOC PRRT.

ESTRO clinical practice guideline on high-dose thoracic reirradiation for non-small cell lung cancer.

Comparison of heart-sparing efficacy between deep inspiration and end-expiration breath-hold in gastric MALT lymphoma radiotherapy: Spatial separation versus margin reduction.

Therapeutic hybrid intelligence with neural and knowledge-based expert reasoning for SRS (THINKERS): an AI model for meningioma.

Patient-specific MU rate optimization to reduce lung dose rate in Volumetric Modulated Arc Therapy-based Total Body Irradiation: A feasibility study.

Preclinical Evaluation in Animals for the Efficacy, Dosimetry, and Safety of [⁶⁸Ga]Ga/[¹⁷⁷Lu]Lu-TVS-PSMA Radioligands, and First-in-Human Study of [⁶⁸Ga]Ga-TVS-PSMA-1.

Cyclotron production of ²⁰⁶Bi for SPECT tracing of bismuth radioisotopes' redistribution in vivo.

Cost-effectiveness of ferumoxtran-enhanced macrophage-specific-MRI and PSMA-PET/CT versus ePLND for nodal staging in primary prostate cancer: a decision analysis based on updated phase-3 trial data.

Infratentorial brain arteriovenous malformations: natural history and long-term outcome-a propensity score matched analysis using nationwide multicenter prospective registry data.

Assessment of potential nephrotoxicity biomarkers after [¹⁷⁷Lu]Lu-DOTA-(Tyr³)-octreotate administration and effects of antioxidant α₁-microglobulin.

Assessment of HyperSight Cone-Beam CT for Dose Calculation in External Regulatory Audit Conditions

Gamma passing rates of sequential boost head and neck VMAT treatment plans: complexity metrics and irradiation phase-specific analysis.

Multifractionation knowledge-based planning model for the stereotactic treatment of ocular tumors.

Automated lesion tracking and treatment response classification on [⁶⁸Ga]Ga-PSMA-11 PET/CT across PPP, RECIP 1.0 and TLW frameworks.

Re: Effect of [68Ga]Ga-PSMA-11 PET-CT in the Diagnosis of Prostate Cancer in Men with Equivocal or Clinically High-risk Non-suspicious Findings in Multiparametric MRI (PRIMARY2): A Multicentre, Non-inferiority, Phase 3, Randomised Controlled Trial.

Development of a Long-Acting FAPI Dimer Albb-2FAPI for Diagnosis and Therapy of FAP-Positive Tumors.

Prognostic Value of a Composite Score Incorporating Baseline [¹⁸F]FDG PET/CT and [⁶⁸Ga]Ga-PSMA-11 PET/CT When Screening for [¹⁷⁷Lu]Lu-PSMA Treatment Eligibility (PROFILE Study).

Clinical Impact and Dynamics of Clonal Hematopoiesis with ¹⁷⁷Lu-PSMA-617 Therapy in Advanced Prostate Cancer.

CBCT dose reduction with HyperSight on an Ethos linear accelerator: A phantom-based TLD measurement study.

External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection.

A Novel Motion-Management Workflow Using Abdominal Compression and Exhale Breath-Hold for Patients With Hepatobiliary Malignancies: A Feasibility Evaluation.

Dosimetric superiority of proton radiosurgery in liver cancer: an in silico comparative dosimetric study.

Prone versus supine radiotherapy for right-sided breast cancer - a retrospective study of radiotherapy plans.

Predicting tumour and organ dose in α-radiopharmaceutical therapy: a ⁸⁹Zr-based dosimetric approach for ²²⁵Ac.

FcRn-Targeted Alpha Therapy Using [²²⁵Ac]Ac-Macropa-Rozanolixizumab Enables Potent Antitumor Activity.